title: Hepatofugal portal flow associated with acute rejection in living-donor auxiliary partial orthotopic liver transplantation: a report of one case and literature review.
abstract: We report a case of reversible hepatofugal portal flow after auxiliary partial orthotopic liver transplantation (APOLT) from a living donor in this study. On postoperative day 6, continuous hepatofugal portal flow was observed in the grafted liver without portal thrombosis and obstruction of the hepatic vein. Based on histological findings, acute rejection was the suspected cause. The normal portal venous flow was restored after steroid pulse and antithymocyte globulin (ATG) therapies. The patient was discharged on the 30th postoperative day. It was concluded that hepatofugal flow after liver transplantation is a sign of serious acute rejection, and can be successfully treated by anti-rejection therapy.
authors.affiliation: Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. weilaitj@hotmail.com
authors.forename: Lai
authors.initials: L
authors.lastname: Wei
authors.forename: Zhishui
authors.initials: Z
authors.lastname: Chen
authors.forename: Xiaoping
authors.initials: X
authors.lastname: Chen
authors.forename: Dunfeng
authors.initials: D
authors.lastname: Du
authors.forename: Kaiyan
authors.initials: K
authors.lastname: Li
authors.forename: Jipin
authors.initials: J
authors.lastname: Jiang
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D006084:Graft Rejection / Q000517:prevention & control*; D006499:Hepatic Artery / Q000000981:diagnostic imaging / Q000502:physiology; D006527:Hepatolenticular Degeneration / Q000601:surgery*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016031:Liver Transplantation / Q000009:adverse effects* / Q000379:methods; D019520:Living Donors; D008297:Male; D011169:Portal Vein / Q000000981:diagnostic imaging / Q000503:physiopathology*; D016559:Tacrolimus / Q000627:therapeutic use; D014463:Ultrasonography
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016559:Tacrolimus